The weeks are ticking down until the launch of Ukraine's Declaration of Conformity (DoC)-based system of medical device regulation on July 1. Old certificates will be invalid after that date, and companies should not be banking on further delays to a system that has already been subject to deadline extensions.

The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.

Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.